214 related articles for article (PubMed ID: 33883692)
1. LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target.
Kang X; Li W; Liu W; Liang H; Deng J; Wong CC; Zhao S; Kang W; To KF; Chiu PWY; Wang G; Yu J; Ng EKW
Oncogene; 2021 May; 40(19):3422-3433. PubMed ID: 33883692
[TBL] [Abstract][Full Text] [Related]
2. Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.
Su B; Su J; Zeng Y; Liu F; Xia H; Ma YH; Zhou ZG; Zhang S; Yang BM; Wu YH; Zeng X; Ai XH; Ling H; Jiang H; Su Q
Oncotarget; 2016 Mar; 7(9):10498-512. PubMed ID: 26871290
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of LIMK1 promotes tumor growth and metastasis in gastric cancer.
You T; Gao W; Wei J; Jin X; Zhao Z; Wang C; Li Y
Biomed Pharmacother; 2015 Feb; 69():96-101. PubMed ID: 25661344
[TBL] [Abstract][Full Text] [Related]
4. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
[TBL] [Abstract][Full Text] [Related]
5. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
[TBL] [Abstract][Full Text] [Related]
6. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.
Okugawa Y; Toiyama Y; Hur K; Toden S; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Kusunoki M; Boland CR; Goel A
Carcinogenesis; 2014 Dec; 35(12):2731-9. PubMed ID: 25280565
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Limk1 caused by microRNA-138 loss aggravates the metastasis of ovarian cancer by activation of Limk1/cofilin signaling.
Chen P; Zeng M; Zhao Y; Fang X
Oncol Rep; 2014 Nov; 32(5):2070-6. PubMed ID: 25190487
[TBL] [Abstract][Full Text] [Related]
8. Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7.
Zhu M; Zhang N; He S; Lu X
Cell Cycle; 2020 May; 19(10):1200-1221. PubMed ID: 32267797
[TBL] [Abstract][Full Text] [Related]
9. Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase-mitogen-activated protein kinases signaling pathway.
Zou D; Song J; Deng M; Ma Y; Yang C; Liu J; Wang S; Wen Z; Tang Y; Qu X; Zhang Y
FASEB J; 2021 May; 35(5):e21601. PubMed ID: 33913201
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer.
Inoue M; Matsumoto S; Saito H; Tsujitani S; Ikeguchi M
Int J Cancer; 2008 Dec; 123(11):2696-701. PubMed ID: 18798274
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway.
Cai S; Chen R; Li X; Cai Y; Ye Z; Li S; Li J; Huang H; Peng S; Wang J; Tao Y; Huang H; Wen X; Mo J; Deng Z; Wang J; Zhang Y; Gao X; Wen X
Oncotarget; 2015 Feb; 6(6):3904-17. PubMed ID: 25714010
[TBL] [Abstract][Full Text] [Related]
15. LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells.
Vlecken DH; Bagowski CP
Zebrafish; 2009 Dec; 6(4):433-9. PubMed ID: 20047470
[TBL] [Abstract][Full Text] [Related]
16. DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
Zhu ZM; Li ZR; Huang Y; Yu HH; Huang XS; Yan YF; Shao JH; Chen HP
Oncol Rep; 2014 Mar; 31(3):1489-97. PubMed ID: 24398929
[TBL] [Abstract][Full Text] [Related]
17. Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression.
McConnell BV; Koto K; Gutierrez-Hartmann A
Mol Cancer; 2011 Jun; 10():75. PubMed ID: 21682918
[TBL] [Abstract][Full Text] [Related]
18. Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer.
Zhao L; Yasumoto K; Kawashima A; Nakagawa T; Takeuchi S; Yamada T; Matsumoto K; Yonekura K; Yoshie O; Yano S
Cancer Sci; 2013 Dec; 104(12):1640-6. PubMed ID: 24118504
[TBL] [Abstract][Full Text] [Related]
19. LIM kinase 1 is required for insulin‑dependent cell growth of osteosarcoma cell lines.
Zhang HS; Zhao JW; Wang H; Zhang HY; Ji QY; Meng LJ; Xing FJ; Yang ST; Wang Y
Mol Med Rep; 2014 Jan; 9(1):103-8. PubMed ID: 24247826
[TBL] [Abstract][Full Text] [Related]
20. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma.
Tanaka H; Yashiro M; Sunami T; Sakate Y; Kosaka K; Hirakawa K
Clin Cancer Res; 2004 Jul; 10(14):4885-92. PubMed ID: 15269165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]